LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 23

Search options

  1. Article ; Online: Publisher Correction: Hypoblast from human pluripotent stem cells regulates epiblast development.

    Okubo, Takumi / Rivron, Nicolas / Kabata, Mio / Masaki, Hideki / Kishimoto, Keiko / Semi, Katsunori / Nakajima-Koyama, May / Kunitomi, Haruko / Kaswandy, Belinda / Sato, Hideyuki / Nakauchi, Hiromitsu / Woltjen, Knut / Saitou, Mitinori / Sasaki, Erika / Yamamoto, Takuya / Takashima, Yasuhiro

    Nature

    2024  Volume 626, Issue 8001, Page(s) E21

    Language English
    Publishing date 2024-02-10
    Publishing country England
    Document type Published Erratum
    ZDB-ID 120714-3
    ISSN 1476-4687 ; 0028-0836
    ISSN (online) 1476-4687
    ISSN 0028-0836
    DOI 10.1038/s41586-024-07166-w
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Current state and outlook for drug repositioning anticipated in the field of ovarian cancer.

    Kobayashi, Yusuke / Banno, Kouji / Kunitomi, Haruko / Tominaga, Eiichiro / Aoki, Daisuke

    Journal of gynecologic oncology

    2018  Volume 30, Issue 1, Page(s) e10

    Abstract: Ovarian cancer is the seventh most common cancer and the eighth most common cause of cancer mortality in women. Although standard chemotherapy is the established treatment for ovarian cancer, the prognosis remains poor, and it is highly anticipated that ... ...

    Abstract Ovarian cancer is the seventh most common cancer and the eighth most common cause of cancer mortality in women. Although standard chemotherapy is the established treatment for ovarian cancer, the prognosis remains poor, and it is highly anticipated that new drugs will be developed. New drugs, such as humanized anti-vascular endothelial growth factor monoclonal antibodies and poly ADP-ribose polymerase inhibitors, are expected to improve clinical outcomes of ovarian cancer. However, long-term, costly research is required to develop such new drugs, and soaring national healthcare costs are becoming a concern worldwide. In this social context, drug repositioning, wherein existing drugs are used to develop drugs with new indications for other diseases, has recently gained attention. Because trials have already confirmed the safety in humans and the pharmacokinetics of such drugs, the development period is shorter than the conventional development of a new drug, thereby reducing costs. This review discusses the available basic experimental and clinical data on drugs used for other types of cancer for which drug repositioning is anticipated to repurpose the drug for the treatment of ovarian cancer. These include statins, which are used to treat dyslipidemia; bisphosphonate, which is used to treat osteoporosis; metformin, which is used to treat diabetes; non-steroidal anti-inflammatory drugs; ivermectin, an antiparasitic agent; and itraconazole, an anti-fungal agent. These drugs will play an important role in future drug repositioning strategies for ovarian cancer. Furthermore, drug repositioning is anticipated to extend not only to ovarian cancer treatment but also to ovarian cancer prevention.
    MeSH term(s) Anti-Inflammatory Agents, Non-Steroidal/pharmacology ; Antifungal Agents/pharmacology ; Antiparasitic Agents/pharmacology ; Carcinoma, Ovarian Epithelial/drug therapy ; Diphosphonates/pharmacology ; Drug Repositioning/economics ; Drug Repositioning/trends ; Female ; Health Care Costs ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology ; Itraconazole/pharmacology ; Ivermectin/pharmacology ; Metformin/pharmacology ; Ovarian Neoplasms/drug therapy
    Chemical Substances Anti-Inflammatory Agents, Non-Steroidal ; Antifungal Agents ; Antiparasitic Agents ; Diphosphonates ; Hydroxymethylglutaryl-CoA Reductase Inhibitors ; Itraconazole (304NUG5GF4) ; Ivermectin (70288-86-7) ; Metformin (9100L32L2N)
    Language English
    Publishing date 2018-10-10
    Publishing country Korea (South)
    Document type Journal Article ; Review
    ZDB-ID 2478405-9
    ISSN 2005-0399 ; 2005-0380
    ISSN (online) 2005-0399
    ISSN 2005-0380
    DOI 10.3802/jgo.2019.30.e10
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Profiling of the Causative Bacteria in Infected Lymphocysts after Lymphadenectomy for Gynecologic Cancer by Pyrosequencing the 16S Ribosomal RNA Gene Using Next-Generation Sequencing Technology.

    Nogami, Yuya / Banno, Kouji / Adachi, Masataka / Kunitomi, Haruko / Kobayashi, Yusuke / Tominaga, Eiichiro / Aoki, Daisuke

    Infectious diseases in obstetrics and gynecology

    2019  Volume 2019, Page(s) 9326285

    Abstract: Background: Surgery for gynecologic cancer with lymphadenectomy and pelvic radiotherapy can produce lymphoceles that sometimes complicate with infection, resulting in abscesses. The true pathogenic bacteria of abscesses are not always found because of ... ...

    Abstract Background: Surgery for gynecologic cancer with lymphadenectomy and pelvic radiotherapy can produce lymphoceles that sometimes complicate with infection, resulting in abscesses. The true pathogenic bacteria of abscesses are not always found because of false-negative results due to administered antibiotics and difficulty with detection, including for anaerobic bacteria. Analyzing bacteria flora by next-generation sequencing (NGS) using 16S ribosomal DNA may reveal the true pathogenic bacteria in abscesses. This is the first report on causative pathogens for infectious lymphocele using this technology.
    Methods: The subjects were patients who developed infectious lymphocele after surgery for gynecologic cancer at our hospital from July 2015 to September 2016. NGS analyses of bacterial flora were performed using specimens preserved at -80°C. Two steps of PCR were performed for purified DNA samples to obtain sequence libraries. Processing of sequence data, including operational taxonomic unit (OTU) definition, taxonomy assignment, and an OTU BLAST search were performed. All patients gave written informed consent and the study was approved by the institutional research ethics committee.
    Results: Six patients underwent puncture and drainage. The result in most cases indicated a single causative pathogen, including
    MeSH term(s) DNA, Bacterial ; DNA, Ribosomal ; Female ; Genital Neoplasms, Female/complications ; Genital Neoplasms, Female/surgery ; High-Throughput Nucleotide Sequencing ; Humans ; Lymph Node Excision/adverse effects ; Lymphocele/etiology ; Lymphocele/microbiology
    Chemical Substances DNA, Bacterial ; DNA, Ribosomal
    Language English
    Publishing date 2019-02-21
    Publishing country Egypt
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1176776-5
    ISSN 1098-0997 ; 1064-7449
    ISSN (online) 1098-0997
    ISSN 1064-7449
    DOI 10.1155/2019/9326285
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: H1FOO-DD promotes efficiency and uniformity in reprogramming to naive pluripotency.

    Kunitomi, Akira / Hirohata, Ryoko / Osawa, Mitsujiro / Washizu, Kaho / Arreola, Vanessa / Saiki, Norikazu / Kato, Tomoaki M / Nomura, Masaki / Kunitomi, Haruko / Ohkame, Tokiko / Ohkame, Yusuke / Kawaguchi, Jitsutaro / Hara, Hiroto / Kusano, Kohji / Yamamoto, Takuya / Takashima, Yasuhiro / Tohyama, Shugo / Yuasa, Shinsuke / Fukuda, Keiichi /
    Takasu, Naoko / Yamanaka, Shinya

    Stem cell reports

    2024  Volume 19, Issue 5, Page(s) 710–728

    Abstract: Heterogeneity among both primed and naive pluripotent stem cell lines remains a major unresolved problem. Here we show that expressing the maternal-specific linker histone H1FOO fused to a destabilizing domain (H1FOO-DD), together with OCT4, SOX2, KLF4, ... ...

    Abstract Heterogeneity among both primed and naive pluripotent stem cell lines remains a major unresolved problem. Here we show that expressing the maternal-specific linker histone H1FOO fused to a destabilizing domain (H1FOO-DD), together with OCT4, SOX2, KLF4, and LMYC, in human somatic cells improves the quality of reprogramming to both primed and naive pluripotency. H1FOO-DD expression was associated with altered chromatin accessibility around pluripotency genes and with suppression of the innate immune response. Notably, H1FOO-DD generates naive induced pluripotent stem cells with lower variation in transcriptome and methylome among clones and a more uniform and superior differentiation potency. Furthermore, we elucidated that upregulation of FKBP1A, driven by these five factors, plays a key role in H1FOO-DD-mediated reprogramming.
    MeSH term(s) Kruppel-Like Factor 4 ; Cellular Reprogramming/genetics ; Humans ; Induced Pluripotent Stem Cells/cytology ; Induced Pluripotent Stem Cells/metabolism ; Histones/metabolism ; Cell Differentiation/genetics ; Kruppel-Like Transcription Factors/metabolism ; Kruppel-Like Transcription Factors/genetics ; SOXB1 Transcription Factors/metabolism ; SOXB1 Transcription Factors/genetics ; Chromatin/metabolism ; Pluripotent Stem Cells/metabolism ; Pluripotent Stem Cells/cytology ; Transcription Factors/metabolism ; Transcription Factors/genetics ; Transcriptome
    Language English
    Publishing date 2024-05-02
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2720528-9
    ISSN 2213-6711 ; 2213-6711
    ISSN (online) 2213-6711
    ISSN 2213-6711
    DOI 10.1016/j.stemcr.2024.04.005
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Hypoblast from human pluripotent stem cells regulates epiblast development.

    Okubo, Takumi / Rivron, Nicolas / Kabata, Mio / Masaki, Hideki / Kishimoto, Keiko / Semi, Katsunori / Nakajima-Koyama, May / Kunitomi, Haruko / Kaswandy, Belinda / Sato, Hideyuki / Nakauchi, Hiromitsu / Woltjen, Knut / Saitou, Mitinori / Sasaki, Erika / Yamamoto, Takuya / Takashima, Yasuhiro

    Nature

    2023  Volume 626, Issue 7998, Page(s) 357–366

    Abstract: Recently, several studies using cultures of human embryos together with single-cell RNA-seq analyses have revealed differences between humans and mice, necessitating the study of human ... ...

    Abstract Recently, several studies using cultures of human embryos together with single-cell RNA-seq analyses have revealed differences between humans and mice, necessitating the study of human embryos
    MeSH term(s) Humans ; Cell Differentiation ; Embryo Implantation ; Embryo, Mammalian/cytology ; Embryo, Mammalian/embryology ; Embryo, Mammalian/metabolism ; Embryonic Development/genetics ; Embryonic Development/physiology ; Germ Layers/cytology ; Germ Layers/embryology ; Germ Layers/metabolism ; Pluripotent Stem Cells/cytology ; Interleukin-6/metabolism ; Gastrula/cytology ; Gastrula/embryology ; Amnion/cytology ; Amnion/embryology ; Amnion/metabolism ; Ectoderm/cytology ; Ectoderm/embryology ; Ectoderm/metabolism ; Intercellular Signaling Peptides and Proteins/genetics ; Intercellular Signaling Peptides and Proteins/metabolism ; Otx Transcription Factors/genetics ; Otx Transcription Factors/metabolism
    Chemical Substances Interleukin-6 ; DKK1 protein, human ; OTX2 protein, human ; IL6 protein, human ; Intercellular Signaling Peptides and Proteins ; Otx Transcription Factors
    Language English
    Publishing date 2023-12-05
    Publishing country England
    Document type Journal Article
    ZDB-ID 120714-3
    ISSN 1476-4687 ; 0028-0836
    ISSN (online) 1476-4687
    ISSN 0028-0836
    DOI 10.1038/s41586-023-06871-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Response Predictive Markers and Synergistic Agents for Drug Repositioning of Statins in Ovarian Cancer.

    Kobayashi, Yusuke / Takeda, Takashi / Kunitomi, Haruko / Chiwaki, Fumiko / Komatsu, Masayuki / Nagai, Shimpei / Nogami, Yuya / Tsuji, Kosuke / Masuda, Kenta / Ogiwara, Hideaki / Sasaki, Hiroki / Banno, Kouji / Aoki, Daisuke

    Pharmaceuticals (Basel, Switzerland)

    2022  Volume 15, Issue 2

    Abstract: In the field of drug repurposing, the use of statins for treating dyslipidemia is considered promising in ovarian cancer treatment based on epidemiological studies and basic research findings. Biomarkers should be established to identify patients who ... ...

    Abstract In the field of drug repurposing, the use of statins for treating dyslipidemia is considered promising in ovarian cancer treatment based on epidemiological studies and basic research findings. Biomarkers should be established to identify patients who will respond to statin treatment to achieve clinical application. In the present study, we demonstrated that statins have a multifaceted mode of action in ovarian cancer and involve pathways other than protein prenylation. To identify biomarkers that predict the response to statins, we subjected ovarian cancer cells to microarray analysis and calculated Pearson's correlation coefficients between gene expression and cell survival after statin treatment. The results showed that
    Language English
    Publishing date 2022-01-21
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2193542-7
    ISSN 1424-8247
    ISSN 1424-8247
    DOI 10.3390/ph15020124
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: The insulin-PI3K-Rac1 axis contributes to terminal adipocyte differentiation through regulation of actin cytoskeleton dynamics.

    Kunitomi, Haruko / Oki, Yoshinao / Onishi, Nobuyuki / Kano, Koichiro / Banno, Kouji / Aoki, Daisuke / Saya, Hideyuki / Nobusue, Hiroyuki

    Genes to cells : devoted to molecular & cellular mechanisms

    2020  Volume 25, Issue 3, Page(s) 165–174

    Abstract: Adipocyte differentiation is accompanied by a pronounced change in the actin cytoskeleton characterized by the reorganization of filamentous (F)-actin stress fibers into cortical F-actin structures. We previously showed that depolymerization of F-actin ... ...

    Abstract Adipocyte differentiation is accompanied by a pronounced change in the actin cytoskeleton characterized by the reorganization of filamentous (F)-actin stress fibers into cortical F-actin structures. We previously showed that depolymerization of F-actin stress fibers induced by inactivation of RhoA-ROCK (Rho-associated kinase) signaling acts as a trigger for adipocyte differentiation. The relevance and underlying mechanism of the formation of cortical F-actin structures from depolymerized actin during adipocyte differentiation have remained unclear, however. We have now examined the mechanistic relation between actin dynamics and adipogenic induction. Transient exposure to the actin-depolymerizing agent latrunculin A (LatA) supported the formation of adipocyte-associated cortical actin structures and the completion of terminal adipocyte differentiation in the presence of insulin, whereas long-term exposure to LatA prevented such actin reorganization as well as terminal adipogenesis. Moreover, these effects of insulin were prevented by inhibition of phosphatidylinositol 3-kinase (PI3K)-Rac1 signaling and the actin-related protein 2/3 (Arp2/3) complex which is a critical component of the cortical actin networks. Our findings thus suggest that the insulin-PI3K-Rac1 axis leads to the formation of adipocyte-associated cortical actin structures which is essential for the completion of adipocyte differentiation.
    MeSH term(s) Actin Cytoskeleton/metabolism ; Adipocytes/metabolism ; Animals ; Cell Differentiation ; Cells, Cultured ; Insulin/metabolism ; Mice ; Neuropeptides/metabolism ; Phosphatidylinositol 3-Kinase/metabolism ; rac1 GTP-Binding Protein/metabolism
    Chemical Substances Insulin ; Neuropeptides ; Rac1 protein, mouse ; Phosphatidylinositol 3-Kinase (EC 2.7.1.137) ; rac1 GTP-Binding Protein (EC 3.6.5.2)
    Language English
    Publishing date 2020-01-29
    Publishing country England
    Document type Journal Article
    ZDB-ID 1330000-3
    ISSN 1365-2443 ; 1356-9597
    ISSN (online) 1365-2443
    ISSN 1356-9597
    DOI 10.1111/gtc.12747
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: LAMC1 is a prognostic factor and a potential therapeutic target in endometrial cancer.

    Kunitomi, Haruko / Kobayashi, Yusuke / Wu, Ren Chin / Takeda, Takashi / Tominaga, Eiichiro / Banno, Kouji / Aoki, Daisuke

    Journal of gynecologic oncology

    2019  Volume 31, Issue 2, Page(s) e11

    Abstract: Objective: With the emerging significance of genetic profiles in the management of endometrial cancer, the identification of tumor-driving genes with prognostic value is a pressing need. The : Methods: We evaluated the immunohistochemical expression ... ...

    Abstract Objective: With the emerging significance of genetic profiles in the management of endometrial cancer, the identification of tumor-driving genes with prognostic value is a pressing need. The
    Methods: We evaluated the immunohistochemical expression of LAMC1 in atypical endometrial hyperplasia and endometrial cancer. Within the endometrial cancer cases, we analyzed the association of LAMC1 overexpression with clinicopathological factors and prognosis. Furthermore, to indentify genes influenced by LAMC1 overexpression, we transfected HEC50B and SPAC-S cells with siRNA targeting
    Results: While none of the atypical endometrial hyperplasia specimens exhibited LAMC1 overexpression, endometrial cancer possessed a significantly higher LAMC1 overexpression rate. LAMC1 overexpression was strongly associated with histological type, lymphovascular space invasion, lymph node metastasis, advanced International Federation of Gynecology and Obstetrics stage, and poor overall survival in endometrial cancer. Gene expression microarray analysis identified 8 genes correlated with tumor progression (
    Conclusion: LAMC1 overexpression is a potent biomarker for identifying endometrial cancer patients needing aggressive adjuvant therapy. We elucidated 8 candidate genes that may mediate progression of LAMC1 overexpressing cancer. Further investigation of the underlying mechanism should lead to the discovery of new therapeutic targets.
    MeSH term(s) Cell Line, Tumor ; Chemotherapy, Adjuvant ; Endometrial Hyperplasia/genetics ; Endometrial Neoplasms/chemistry ; Endometrial Neoplasms/genetics ; Endometrial Neoplasms/pathology ; Endometrium/chemistry ; Endometrium/pathology ; Female ; Gene Expression ; Gene Silencing ; Humans ; Laminin/analysis ; Laminin/genetics ; Lymphatic Metastasis/genetics ; Neoplasm Invasiveness/genetics ; Neoplasm Staging ; Prognosis ; Protein Array Analysis ; RNA, Small Interfering/genetics ; Survival Rate ; Transfection
    Chemical Substances Laminin ; RNA, Small Interfering ; laminin gamma 1
    Language English
    Publishing date 2019-08-21
    Publishing country Korea (South)
    Document type Journal Article
    ZDB-ID 2478405-9
    ISSN 2005-0399 ; 2005-0380
    ISSN (online) 2005-0399
    ISSN 2005-0380
    DOI 10.3802/jgo.2020.31.e11
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: ROCK Inhibition Induces Terminal Adipocyte Differentiation and Suppresses Tumorigenesis in Chemoresistant Osteosarcoma Cells.

    Takahashi, Nobuhiro / Nobusue, Hiroyuki / Shimizu, Takatsune / Sugihara, Eiji / Yamaguchi-Iwai, Sayaka / Onishi, Nobuyuki / Kunitomi, Haruko / Kuroda, Tatsuo / Saya, Hideyuki

    Cancer research

    2019  Volume 79, Issue 12, Page(s) 3088–3099

    Abstract: Tumors comprise heterogeneous cell types including cancer stem cells (CSC), progenitor cells, and differentiated cells. Chemoresistance is a potential cause of relapse and a key characteristic of CSC, but the development of novel therapeutic approaches ... ...

    Abstract Tumors comprise heterogeneous cell types including cancer stem cells (CSC), progenitor cells, and differentiated cells. Chemoresistance is a potential cause of relapse and a key characteristic of CSC, but the development of novel therapeutic approaches for targeting these cells has been limited. We previously established osteosarcoma-initiating (OSi) cells by introducing the gene for c-Myc into bone marrow stromal cells of
    MeSH term(s) Actin Cytoskeleton/drug effects ; Adipocytes/cytology ; Adipocytes/drug effects ; Adipocytes/metabolism ; Animals ; Antineoplastic Agents/pharmacology ; Bone Neoplasms/metabolism ; Bone Neoplasms/pathology ; Bone Neoplasms/prevention & control ; Carcinogenesis/drug effects ; Carcinogenesis/metabolism ; Carcinogenesis/pathology ; Cell Differentiation ; Cell Proliferation ; Cells, Cultured ; Drug Resistance, Neoplasm/drug effects ; Male ; Mesenchymal Stem Cells/cytology ; Mesenchymal Stem Cells/drug effects ; Mesenchymal Stem Cells/metabolism ; Mice ; Mice, Inbred C57BL ; Neoplastic Stem Cells/drug effects ; Neoplastic Stem Cells/metabolism ; Neoplastic Stem Cells/pathology ; Osteosarcoma/metabolism ; Osteosarcoma/pathology ; Osteosarcoma/prevention & control ; rho-Associated Kinases/antagonists & inhibitors
    Chemical Substances Antineoplastic Agents ; rho-Associated Kinases (EC 2.7.11.1)
    Language English
    Publishing date 2019-04-16
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1432-1
    ISSN 1538-7445 ; 0008-5472
    ISSN (online) 1538-7445
    ISSN 0008-5472
    DOI 10.1158/0008-5472.CAN-18-2693
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Warburg effect in Gynecologic cancers.

    Kobayashi, Yusuke / Banno, Kouji / Kunitomi, Haruko / Takahashi, Takayuki / Takeda, Takashi / Nakamura, Kanako / Tsuji, Kosuke / Tominaga, Eiichiro / Aoki, Daisuke

    The journal of obstetrics and gynaecology research

    2018  Volume 45, Issue 3, Page(s) 542–548

    Abstract: Mammalian cells produce energy by oxidative phosphorylation under aerobic conditions. However, in the 1920s, Otto Warburg reported the so-called "Warburg effect" in which cancer cells produce ATP that is biased toward glycolysis rather than mitochondrial ...

    Abstract Mammalian cells produce energy by oxidative phosphorylation under aerobic conditions. However, in the 1920s, Otto Warburg reported the so-called "Warburg effect" in which cancer cells produce ATP that is biased toward glycolysis rather than mitochondrial oxidative phosphorylation not only in anaerobic environment but also in aerobic environment. Glucose is converted into lactate without going into mitochondria after being metabolized in glycolysis. Compared with oxidative phosphorylation, the glycolysis has a faster ATP production rate but it is very inefficient, resulting in cancer cells consuming a large amount of glucose. Increased glucose metabolism has become a biomarker for cancer cells and has led to the development of positron emission tomography with fluorodeoxyglucose. Till date, the Warburg effect has been an inefficient system for cancer cells with regard to efficient energy production, but since the consumption of oxygen can be suppressed as the tumor grows in mass, it is thought that the Warburg effect is advantageous in this situation wherein the tumor can increase despite the lack of vessels. In addition, an increased lactate by the glycolysis causes acidosis in the microenvironment of tissues, which is thought to damage the surrounding normal tissues and favor the invasion and metastasis of cancer. Thus, Warburg effect is one of the key mechanisms for cancer development and will be the next promising target. In this review, we introduce key players that can be targeted in the Warburg effect and outline the prospects of treatment, targeting the Warburg effect in gynecological cancer.
    MeSH term(s) Female ; Genital Neoplasms, Female/metabolism ; Genital Neoplasms, Female/pathology ; Glycolysis/physiology ; Humans ; Mitochondria/metabolism ; Mitochondria/pathology ; Neoplasms/metabolism ; Neoplasms/pathology ; Oxidative Phosphorylation
    Language English
    Publishing date 2018-12-03
    Publishing country Australia
    Document type Journal Article ; Review
    ZDB-ID 1327307-3
    ISSN 1447-0756 ; 1341-8076
    ISSN (online) 1447-0756
    ISSN 1341-8076
    DOI 10.1111/jog.13867
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top